143 related articles for article (PubMed ID: 34206357)
1. Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma.
Hailat M; Al-Ani I; Hamad M; Zakareia Z; Abu Dayyih W
Molecules; 2021 Jun; 26(13):. PubMed ID: 34206357
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a sensitive, fast and simple LC-MS / MS method for the quantitation of favipiravir in human serum.
Eryavuz Onmaz D; Abusoglu S; Onmaz M; Yerlikaya FH; Unlu A
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1176():122768. PubMed ID: 34052564
[TBL] [Abstract][Full Text] [Related]
3. Menthol-assisted homogenous liquid-liquid microextraction for HPLC/UV determination of favipiravir as an antiviral for COVID-19 in human plasma.
Abdallah IA; Hammad SF; Bedair A; Mansour FR
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan; 1189():123087. PubMed ID: 34974319
[TBL] [Abstract][Full Text] [Related]
4. QbD-Based Stability-Indicating RP-HPLC Method Development and Validation for the Estimation of Favipiravir-An Eco-Friendly Approach.
Chandana M S; K S; A A; Narendra P; K S
J AOAC Int; 2024 May; 107(3):377-386. PubMed ID: 38318977
[TBL] [Abstract][Full Text] [Related]
5. Determination of favipiravir in human plasma using homogeneous liquid-liquid microextraction followed by HPLC/UV.
Abdallah IA; Hammad SF; Bedair A; Elshafeey AH; Mansour FR
Bioanalysis; 2022 Feb; 14(4):205-216. PubMed ID: 35001648
[No Abstract] [Full Text] [Related]
6. Experimental design approach for development of spectrofluorimetric method for determination of favipiravir; a potential therapeutic agent against COVID-19 virus: Application to spiked human plasma.
Megahed SM; Habib AA; Hammad SF; Kamal AH
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Mar; 249():119241. PubMed ID: 33333412
[TBL] [Abstract][Full Text] [Related]
7. An Eco-Friendly RP-HPLC Method Development and Validation for Quantification of Favipiravir in Bulk and Tablet Dosage Form Followed by Forced Degradation Study.
Sangani MB; Patel N
J Chromatogr Sci; 2024 May; 62(5):432-438. PubMed ID: 38266038
[TBL] [Abstract][Full Text] [Related]
8. HPLC-fluorescence assay for acyclovir in children.
Zeng L; Nath CE; Shaw PJ; Earl JW; McLachlan AJ
Biomed Chromatogr; 2008 Aug; 22(8):879-87. PubMed ID: 18348336
[TBL] [Abstract][Full Text] [Related]
9. Technique validation by liquid chromatography for the determination of acyclovir in plasma.
Fernández M; Sepúlveda J; Aránguiz T; von Plessing C
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):357-63. PubMed ID: 12798195
[TBL] [Abstract][Full Text] [Related]
10. HPLC-DAD quantification of favipiravir in whole blood after extraction from volumetric absorptive microsampling devices.
Azzahra Rahmadhani C; Harahap Y; Aisyah Rahmania T
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1215():123547. PubMed ID: 36586341
[TBL] [Abstract][Full Text] [Related]
11. Determination of acyclovir in maternal plasma, amniotic fluid, fetal and placental tissues by high-performance liquid chromatography.
Brown SD; White CA; Chu CK; Bartlett MG
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 772(2):327-34. PubMed ID: 12007778
[TBL] [Abstract][Full Text] [Related]
12. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
[TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS method for the determination of clodronate in human plasma.
Hasan M; Schumacher G; Seekamp A; Taedken T; Siegmund W; Oswald S
J Pharm Biomed Anal; 2014 Nov; 100():341-347. PubMed ID: 25194348
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum.
Habler K; Brügel M; Teupser D; Liebchen U; Scharf C; Schönermarck U; Vogeser M; Paal M
J Pharm Biomed Anal; 2021 Mar; 196():113935. PubMed ID: 33548872
[TBL] [Abstract][Full Text] [Related]
15. Core-shell nanocomposite of flower-like molybdenum disulfide nanospheres and molecularly imprinted polymers for electrochemical detection of anti COVID-19 drug favipiravir in biological samples.
Wang S; Wang C; Xin Y; Li Q; Liu W
Mikrochim Acta; 2022 Mar; 189(3):125. PubMed ID: 35229221
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an RP-HPLC method to quantitate acyclovir in cross-linked chitosan microspheres produced by spray drying.
Stulzer HK; Tagliari MP; Murakami FS; Silva MA; Laranjeira MC
J Chromatogr Sci; 2008 Jul; 46(6):496-500. PubMed ID: 18647469
[TBL] [Abstract][Full Text] [Related]
17. Validation of a simple bioanalytical method for the determination of DRF-6196, a novel oxazolidinone, in mouse plasma: application to a single-dose pharmacokinetic study.
Dravid PV; Bhamidipati RK; Mullangi R; Srinivas NR
Arzneimittelforschung; 2005; 55(4):239-44. PubMed ID: 15901048
[TBL] [Abstract][Full Text] [Related]
18. Simple and rapid RP-HPLC method for simultaneous determination of acyclovir and zidovudine in human plasma.
Sharma M; Nautiyal P; Jain S; Jain D
J AOAC Int; 2010; 93(5):1462-7. PubMed ID: 21140658
[TBL] [Abstract][Full Text] [Related]
19. A novel, rapid and simple UPLC-MS/MS method for quantification of favipiravir in human plasma: Application to a bioequivalence study.
Rezk MR; Badr KA; Abdel-Naby NS; Ayyad MM
Biomed Chromatogr; 2021 Jul; 35(7):e5098. PubMed ID: 33606892
[TBL] [Abstract][Full Text] [Related]
20. Analysis of acyclovir in vitreous humor by a validated HPLC method.
Silva GR; Caldeira AS; Damico FM; Takahashi BS; Silva-Cunha A; Fialho SL
Pharmazie; 2013 Apr; 68(4):235-9. PubMed ID: 23700787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
